* Download API list in PDF format

# Name Cas Number Status Standard DMF Therapeutic area
1 Abiraterone 154229-19-3 Pilot USP Filing in process Oncology
2 Alogliptin Benzoate 850649-62-6 Validated In-house Ready Diabetes
3 Aprepitant 170729-80-3 Validated USP /EP Ready Oncology
4 Azilsartan 147403-03-0 Pilot In-house Filing in process Cardiovascular Hypertension
5 Benazepril HCl 86541-74-4 Validated USP/EP DMF: 025738 Cardiovascular
6 Butylphthalide 6066-49-5 Validated In-house Ready Nervous System
7 Canagliflozin 842133-18-0 Pilot In-house Diabetes
8 Capecitabine 154361-50-9 Pilot EP/USP Filing in process Oncology
9 Clinofibrate 30299-08-2 Validated JP AG10500422 Cardiovascular
10 Dapagliflozin propanediol monohydrate 461432-26-8 --- --- Diabetes
11 Diacerein 13739-02-1 Validated EP Ready Analgesic
12 Dolutegravir 1051375-19-9 Pilot In-house Filing in process Viral
13 Dronedarone HCl 141625-93-6 Validated USP DMF: 026593 Cardiovascular
14 Eluxadoline 864821-90-9 Pilot In-house Filing in process Gastrointestinal agent
15 Empagliflozin 864070-44-0 --- --- Diabetes Type 2
16 Entecavir 209216-23-9 Validated EP/USP DMF:027444 Viral
17 Esomeprazole Mg 217087-09-7 Validated USP/EP Filing in process Gastrointestinal agent
18 Esomeprazole Na 161796-78-7 Pilot In-house Filing in process Gastrointestinal agent
19 Fasudil HCl 105628-07-7 Validated ChP DMF: 026740 Cardiovascular
20 Fenofibric acid 42017-89-0 Pilot In-house Filing in process Cardiovascular
21 Flupirtine Maleate 75507-68-5 Validated In-house DMF: 026931 Analgesic
22 Flurbiprofen axetil 91503-79-6 Validated In-house Ready Analgesic
23 Fondaparinux sodium 114870-03-0 Pilot In-house Filing in process Cardiovascular
24 Fosaprepitant dimeglumine 265121-04-8 Validated In-house Filing in process Oncology
25 Fulvestrant 129453-61-8 Pilot USP/EP Filing in process Oncology
26 Gefitinib 184475-35-2 Pilot EP Filing in process Oncology
27 Ibrutinib 936563-96-1 Validated In-house Filing in process Oncology
28 Ledipasvir 1441674-54-9 Validated In-house Filing in process Viral
29 Linagliptin 668270-12-0 Pilot In-house Filing in process Diabetes
30 Rivaroxaban 366789-02-8 Pilot In-house Filing in process Cardiovascular
31 Sofosbuvir 1190307-88-0 Validated In-house Filing in process Viral
32 Ticagrelor 274693-27-5 Pilot In-house Filing in process Cardiovascular -Antithrombotic agents
33 Tirofiban HCl 150915-40-5 Validated In-house DMF: 026942 Cardiovascular
34 Velpatasvir 1377049-84-7 Pilot In-house Filing in process Viral

Notes

* Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

* Download API list in PDF format

Analgesic API

# Name Cas Number Status Standard DMF Therapeutic area
1 Diacerein 13739-02-1 Validated EP Ready Analgesic
2 Flupirtine Maleate 75507-68-5 Validated In-house DMF: 026931 Analgesic
3 Flurbiprofen axetil 91503-79-6 Validated In-house Ready Analgesic

Cardiovascular API

# Name Cas Number Status Standard DMF Therapeutic area
1 Azilsartan 147403-03-0 Pilot In-house Filing in process Cardiovascular Hypertension
2 Benazepril HCl 86541-74-4 Validated USP/EP DMF: 025738 Cardiovascular
3 Clinofibrate 30299-08-2 Validated JP AG10500422 Cardiovascular
4 Dronedarone HCl 141625-93-6 Validated USP DMF: 026593 Cardiovascular
5 Fasudil HCl 105628-07-7 Validated ChP DMF: 026740 Cardiovascular
6 Fenofibric acid 42017-89-0 Pilot In-house Filing in process Cardiovascular
7 Fondaparinux sodium 114870-03-0 Pilot In-house Filing in process Cardiovascular
8 Rivaroxaban 366789-02-8 Pilot In-house Filing in process Cardiovascular
9 Ticagrelor 274693-27-5 Pilot In-house Filing in process Cardiovascular -Antithrombotic agents
10 Tirofiban HCl 150915-40-5 Validated In-house DMF: 026942 Cardiovascular

Diabetes API

# Name Cas Number Status Standard DMF Therapeutic area
1 Alogliptin Benzoate 850649-62-6 Validated In-house Ready Diabetes
2 Canagliflozin 842133-18-0 Pilot In-house Diabetes
3 Dapagliflozin propanediol monohydrate 461432-26-8 --- --- Diabetes
4 Empagliflozin 864070-44-0 --- --- Diabetes
5 Linagliptin 668270-12-0 Pilot In-house Filing in process Diabetes

Gastrointestinal API

# Name Cas Number Status Standard DMF Therapeutic area
1 Eluxadoline 864821-90-9 Pilot In-house Filing in process Gastrointestinal agent
2 Esomeprazole Mg 217087-09-7 Validated USP/EP Filing in process Gastrointestinal agent
3 Esomeprazole Na 161796-78-7 Pilot In-house Filing in process Gastrointestinal agent

Oncology API

# Name Cas Number Status Standard DMF Therapeutic area
1 Abiraterone 154229-19-3 Pilot USP Filing in process Oncology
2 Aprepitant 170729-80-3 Validated USP /EP Ready Oncology
3 Capecitabine 154361-50-9 Pilot EP/USP Filing in process Oncology
4 Fosaprepitant dimeglumine 265121-04-8 Validated In-house Filing in process Oncology
5 Fulvestrant 129453-61-8 Pilot USP/EP Filing in process Oncology
6 Gefitinib 184475-35-2 Pilot EP Filing in process Oncology
7 Ibrutinib 936563-96-1 Validated In-house Filing in process Oncology

Viral API

# Name Cas Number Status Standard DMF Therapeutic area
1 Dolutegravir 1051375-19-9 Pilot In-house Filing in process Viral
2 Entecavir 209216-23-9 Validated EP/USP DMF:027444 Viral
3 Ledipasvir 1441674-54-9 Validated In-house Filing in process Viral
4 Sofosbuvir 1190307-88-0 Validated In-house Filing in process Viral
5 Velpatasvir 1377049-84-7 Pilot In-house Filing in process Viral

Nervous System API

# Name Cas Number Status Standard DMF Therapeutic area
1 Butylphthalide 6066-49-5 Validated In-house Ready Nervous System

Notes

* Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

* Download API list Veterinary use

Veterinary API Products

# Name Cas Number Status Standard DMF Note
1 Tulathromycin 217500-96-4 Validated In-house --- It is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs.
2 Pimobendan 74150-27-9 Validated EP/USP --- Pimobendan is used in the management of heart failure in dogs
3 Imidacloprid 138261-41-3 Pilot EP Pending --- ---
4 Firocoxib 189954-96-9 Pilot In-house --- It is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, use in dogs and horses.
5 Maropitant 359875-09-5 Pilot In-house --- Use for the treatment of motion sickness and vomiting in dogs

Notes

* Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Below you find intermediates of :

* Alogliptin, Anagliptin, Aprepitant, Bendamustine, Carfilzomib, Dolutegravir, Eluxadoline, Entecavir, Fosaprepitant, Fulvestrant, Ibrutinib, Idelalisib, Ledipasvir, Linagliptin, Rivaroxaban, Sofosbuvir, Ticagrelor, Velpatasvir, Vilanterol.

* Download intermediate list in PDF format

Alogliptin

# Name Cas Number Structure Status Technical Pack Note
1 Benzonitrile, 2-[(6-chloro-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)methyl]- 865758-95-8 ----- ----- ----- -----
2 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile 865758-96-9 ----- ----- ----- -----
3 (R)-3-Piperidinamine dihydrochloride 334618-23-4 ---- ---- --- -----

Anagliptin

# Name Cas Number Structure Status Technical Pack Note
1 2-Methylpyrazolo[1,5-A]pyrimidine-6-carboxylic acid 739364-95-5 ------ ----- ----- ----- -----
2 (2S)-1-[[(2-Amino-1,1-dimethylethyl)amino]acetyl]-2-pyrrolidinecarbonitrile 794460-89-2 ------ ----- ----- ----- -----
3 (2-Amino-2-Methyl-Propyl)-Carbamic Acid Tert-Butyl Ester 95034-05-2 ------ ----- ----- ----- -----
4 2-Formyl-3-oxo-propanoic acid ethyl ester 80370-42-9 ------ ----- ----- ----- -----

Aprepitant

# Name Cas Number Structure Status Technical Pack Note
1 N-Methylcarbonyl-2-chloroacetamidrazone 155742-64-6 ------ ----- ----- ----- -----
2 (2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine hydrochloride 171482-05-6 ------ ----- ----- ----- -----

Bendamustine

# Name Cas Number Structure Status Technical Pack Note
1 1-Methyl-5-amino-1H-benzimidazole-2-butanoic Acid Ethyl Ester 3543-73-5 ------ ----- ----- ----- -----
2 [1-Methyl-5-bis(2'-hydroxyethyl)aminobenzimidazolyl-2]butanoic Acid Ethyl Ester 3543-74-6 ------ ----- ----- ----- -----

Carfilzomib

# Name Cas Number Structure Status Technical Pack Note
1 (2S)-2-Amino-4-methyl-1-[(2R)-2-methyloxiranyl]-1-pentanone trifluoroacetate 247068-85-5 ------ ----- ----- ----- -----
2 [(1S)-3-Methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]carbamic acid 1,1-dimethylethyl ester 247068-82-2 ------ ----- ----- ----- -----

Dolutegravir

# Name Cas Number Structure Status Technical Pack Note
1 Dolutegravir 1051375-16-6 ------ ----- ----- ----- -----
2 dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate 1246616-66-9 ------ ----- ----- ----- -----
3 5-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1-(2,2-dimethoxyethyl)-1,4-dihydro-4-oxo-3-(phenylmethoxy)-2-pyridinecarboxylic acid methyl ester 1229006-21-6 ------ ----- ----- ----- -----
4 (4R,12aS)-N-(2,4-difluorobenzyl)-7-benzylhydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide 1206102-11-5 ------ ----- ----- ----- -----

Eluxadoline

# Name Cas Number Structure Status Technical Pack Note
1 4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine 623950-02-7 ------ ----- ----- ----- -----
2 (alpha)-α-Methyl-4-phenyl-1H-imidazole-2-methanamine 864825-23-0 ------ ----- ----- ----- -----

Entecavir

# Name Cas Number Structure Status Technical Pack Note
1 (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol 142217-78-5 ------ ----- ----- ----- -----
2 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine 142217-80-9 ------ ----- ----- ----- -----
3 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one 142217-81-0 ------ ----- ----- ----- -----

Fosaprepitant

# Name Cas Number Structure Status Technical Pack Note
1 Pyrophosphoric acid tetrabenzyl ester 990-91-0 ------ ----- ----- ----- -----

Fulvestrant

# Name Cas Number Structure Status Technical Pack Note
1 Estra-1,3,5(10)-triene-3,17-diol,7-(9-bromononyl)-,17-acetate,(7a,17b)- 875573-66-3 ------ ----- ----- ----- -----
2 (7α,17β)-7-[9-(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3-diol-17oxyethyl 875573-69-6 ------ ----- ----- ----- -----

Ibrutinib

# Name Cas Number Structure Status Technical Pack Note
1 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylamine 330786-24-8 ------ ----- ----- ----- -----

Idelalisib

# Name Cas Number Structure Status Technical Pack Note
1 2-fluoro-6-nitro-N-phenylbenzamide 870281-83-7 ------ ----- ----- ----- -----
2 L-2-(boc-amino)butyric acid 34306-42-8 ------ ----- ----- ----- -----
3 6-chloro-9-tetrahydro-2-pyranyl-purine 7306-68-5 ------ ----- ----- ----- -----
4 Carbamic acid, [(1S)-1-[[(2-fluoro-6-nitrobenzoyl)phenylamino]carbonyl]propyl]-, 1,1-dimethylethyl ester 870281-84-8 ------ ----- ----- ----- -----
5 (S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one 870281-86-0 ------ ----- ----- ----- -----

Ledipasvir

# Name Cas Number Structure Status Technical Pack Note
1 L-Valine, N-(methoxycarbonyl)- 74761-42-5 ------ ----- ----- ----- -----
2 (S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid 1129634-44-1 ------ ----- ----- ----- -----
3 (6S)-5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid 5-(1,1-dimethylethyl) ester potassium salt (1:1) 1441673-92-2 ------ ----- ----- ----- -----
4 (6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester 1441670-89-8 ------ ----- ----- ----- -----
5 (1R,3S,4S)-3-(6-Bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester 1256387-74-2 ------ ----- ----- ----- -----
6 1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone 1378387-81-5 ------ ----- ----- ----- -----
7 (1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid 291775-59-2 ------ ----- ----- ----- -----
8 ------ 1256388-49-4 ------ ----- ----- ----- -----

Linagliptin

# Name Cas Number Structure Status Technical Pack Note
1 1-bromo-2-butyne 3355-28-0 ------ ----- ----- ----- -----
2 3-Methyl-8-bromoxanthine 93703-24-3 ------ ----- ----- ----- -----
3 Quinazoline, 2-(chloromethyl)-4-methyl- 109113-72-6 ------ ----- ----- ----- -----
4 3-(R)-Piperidinyl Phthalimide D-(-)-tartaric acid 886588-62-1 ------ ----- ----- ----- -----
5 (R)-3-(Boc-Amino)piperidine 309956-78-3 ------ ----- ----- ----- -----
6 (R)-3-aminopiperidine dihydrochloride 334618-23-4 ------ ----- ----- ----- -----

Rivaroxaban

# Name Cas Number Structure Status Technical Pack Note
1 4-(4-aminophenyl)morpholin-3-one 438056-69-0 ------ ----- ----- ----- -----
2 (S)-(+)-Glycidyl Phthalimide 161596-47-0 ------ ----- ----- ----- -----
3 5-Chlorothiophene-2-carbonyl chloride 42518-98-9 ------ ----- ----- ----- -----
4 4-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one 446292-10-0 ------ ----- ----- ----- -----

Sofosbuvir

# Name Cas Number Structure Status Technical Pack Note
1 ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate 874638-80-9 ------ ----- ----- ----- -----
2 Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-dibenzoate,(2'R)- 817204-32-3 ------ ----- ----- ----- -----
3 2'-deoxy-2'-fluoro-2'-C-methyluridine 863329-66-2 ------ ----- ----- ----- -----
4 Isopropyl N-[(pentafluorophenoxy)(phenoxy)phosphoryl]-L-alaninate 1334513-02-8 ------ ----- ----- ----- -----

Ticagrelor

# Name Cas Number Structure Status Technical Pack Note
1 (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine hydrochloride 1156491-10-9 ------ ----- ----- ----- -----

Velpatasvir

# Name Cas Number Structure Status Technical Pack Note
1 (2R,4R)-1-tert-butyl2-(2-(9-((2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carbonyloxy)-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl)4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate 1378391-43-5 ------ ----- ----- ----- -----

Vilanterol

# Name Cas Number Structure Status Technical Pack Note
1 Vilanterol 503068-34-6 ------ ----- ----- ----- -----
2 ------ 452339-73-0 ------ ----- ----- ----- -----
3 ------ 503070-57-3 ------ ----- ----- ----- -----
4 Triphenyl acetic acid 595-91-5 ------ ----- ----- ----- -----

Notes

* Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

* Downloads

Recent Projects

Eribulin Mesylate

CAS : 441045-17-6
* RD stage
* Synthetic route selection
* Sample preparation

Fondaparinux sodium

CAS : 114870-03-0
* Synthetic route optimization
* Pilot study
* Kilo scale preparation

Ibrutinib

CAS : 936563-96-1
* Not infringe patent
* Commercialized

Ertugliflozin

CAS : 1210344-57-2
Code Name: PF-04971729
* Not infringe patent
* Synthetic route optimization
* Kilo scale preparation

Fosaprepitant dimeglumine

CAS : 265121-04-8
* Process Validated
* DMF : In progress
* Standard : In House
* Kilo scale preparation

Inspection

  • USFDA
  • EDQM
  • PMDA
  • MFDS
  • CFDA
  • MOA

Read more..